Bank Of Montreal Fulgent Genetics, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$47.98 - $62.75 $125,611 - $164,279	-2,618 Reduced 39.96%	3,933 $225,000
Q1 2022 May 12, 2022	BUY	$49.85 - $96.11 $22,980 - $44,306	461 Added 7.57%	6,551 $410,000
Q4 2021 Feb 11, 2022	SELL	$77.3 - $105.0 $101,804 - $138,285	-1,317 Reduced 17.78%	6,090 $622,000
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $436,716 - $646,704	-5,833 Reduced 44.06%	7,407 $671,000
Q2 2021 Aug 12, 2021	BUY	$66.8 - $100.45 $884,432 - $1.33 Million	13,240 New	13,240 $1.27 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.